NamasteMD Announces Acquisition of 28,000 Registered Users Representing a 48% Monthly Increase and 23,000 Downloads of the Uppy Strain Journal
Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV:N.V) (M5BQ.F) (NXTTF) is pleased to announce that the Company has acquired over 28,000 registered users through NamasteMD Inc. (“NamasteMD”), and that the Uppy Strain Journal (“Uppy” or “Uppy.com”) has now been downloaded over 23,000 times. The NamasteMD app is available on iOS and Android devices and online at NamasteMD.com. NamasteMD is an online platform which provides free access to medical cannabis consultations through secure video conferencing. The Uppy Strain Journal collects user-generated data on cannabis strains and their impact on various medical conditions.
N.V)(NXTTF)(M5BQ.F) (CNW Group/Namaste Technologies Inc.)” alt=”Namaste Technologies Inc. (TSXV:N.V)(NXTTF)(M5BQ.F) (CNW Group/Namaste Technologies Inc.)” />
NamasteMD’s recent growth is attributed to an increase in organic traffic and patient referrals, and represents a 48% increase from the previous month. NamasteMD connects patients with licensed producers including the Company’s wholly-owned subsidiary, Cannmart Inc. (“Cannmart”) to purchase medical cannabis products. The Company anticipates further growth of the NamasteMD platform and has expanded its network of healthcare consultants to meet demand. The Company also intends on submitting the app to the Apple and Google Play stores in the UK, where it will leverage its existing database of over 500,000 users to develop a similar model to its Canadian market. Namaste is continuously looking to expand its platform in other regions where telemedicine and cannabis become legalized. With over 1.5 million customers globally and Namaste operating in over 20 countries, the Company will have a competitive advantage in emerging markets.
The Company is also pleased to report that its cannabis journaling app, the Uppy Strain Journal has been downloaded on over 23,000 devices. Data collection through Uppy will drive machine learning algorithms that will be used in tandem with cannabis strain data to provide patients with enhanced strain recommendations. By adding value for medical patients in an online environment, the Company anticipates achieving a lower cost per patient acquisition, higher conversion rates, increased revenue and provide a better user experience.
The Company’s goal is to offer a fully-integrated and truly unbiased online marketplace for medical cannabis with a diverse selection of products, where user feedback through Uppy, better strain recommendations and an emphasis on customer service provide an exceptional user experience. The overall platform guides patients from consultation through prescription and ordering from Cannmart within the same day. Cannmart has been processing and shipping orders with next-day delivery and will soon be integrated with its partner, Pineapple Express Inc. (“Pineapple Express”) to offer same-day delivery in the GTA area.
Management Commentary:
Sean Dollinger , President and CEO of Namaste comments: “We’re proud to be at the point where we can have someone place an order within an hour of being seen by a nurse practitioner, which we believe to be the best turn-around time in the industry. Our goal is to streamline the process of acquiring medical documentation and accessing medical cannabis through an online marketplace and in offering the best user experience possible. We’re looking forward to launching same-day delivery with Pineapple Express and on continued growth. We have received positive feedback from Cannmart patients and will continue to optimize the platform and add new features to bring value to our patients.”
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com